Patents by Inventor Norio Oyabu

Norio Oyabu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200270243
    Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: October 4, 2018
    Publication date: August 27, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shinji NAKAMURA, Satoshi MIKAMI, Tomoaki HASUI, Tohru YAMASHITA, Shinji MORIMOTO, Hidekazu TOKUHARA, Norio OYABU, Masami YAMADA, Atsuko OCHIDA, Kazuaki TAKAMI, Xin LIU
  • Publication number: 20200207734
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: August 2, 2018
    Publication date: July 2, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Publication number: 20200017444
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Patent number: 4929667
    Abstract: A urethane prepolymer composition is provided comprising (a) a terminal isocyanate group-containing urethane prepolymer derived from a polytetramethylene glycol having a specific molecular weight of 700 to 1500 and an aliphatic and/or alicyclic diisocyanate and (b) a terminal isocyanate group-containing urethane prepolymer derived from a polycaprolactone diol and/or polyol having a specific molecular weight of 500 to 1500 and an aliphatic and/or alicyclic diisocyanate, the weight ratio of (a) to (b) being in the range of 80/20 to 20/80. This composition has excellent compatibility with a diol compound and/or a polyol compound, and can be formulated together with the diol compound and/or the polyol compound into a polyurethane coating composition system which forms a coating film having not only excellent weathering resistance, elastic recovery and transparency but also excellent low-temperature physical properties such as mechanical strength, flexibility and impact resistance at low temperatures, e.g., -30.
    Type: Grant
    Filed: February 1, 1989
    Date of Patent: May 29, 1990
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Kazuki Ban, Norio Oyabu
  • Patent number: 4801663
    Abstract: A novel isocyanurate polyisocyanate is disclosed containing N,N',N"-tris(6-isocyanatohexyl)-isocyanurate in an extremely high proportion and having an extremely low viscosity. The novel isocyanurate polyisocyanate is excellent not only in compatibility with a polyol having a low polarity but also in solubility in a solvent having a low polarity as well as in a polar solvent. The novel isocyanurate polyisocyanate is very useful as a curing agent for a two-component polyurethane composition, especially a two-component polyurethane coating composition. The two-component polyurethane coating composition of the present invention is capable of providing a coat film having extremely excellent properties.
    Type: Grant
    Filed: March 29, 1988
    Date of Patent: January 31, 1989
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Kaoru Ueyanagi, Norio Oyabu, Yoshiyuki Asahina
  • Patent number: 4007151
    Abstract: A solventless polyurethane coating composition having a low viscosity suitable for coating, which comprises (a) an aliphatic or alicyclic polyisocyanate containing at least 3 isocyanate groups, (b) at least 1/3 equivalent, based on the isocyanate groups, of a monohydric alcohol, and (c) a low-molecular-weight polyhydric alcohol having at least 3 active hydrogen atoms. The composition provides coatings having superior properties such as good hardness, weatherability and intimate adhesion to a substrate.
    Type: Grant
    Filed: June 2, 1975
    Date of Patent: February 8, 1977
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Shinsaku Ogawa, Matsuei Yamanoue, Norio Oyabu